J. Luka

发表

Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000-dalton subunit

G. Klein, H. Jörnvall, J. Luka, 1980, Journal of virology.

Development of a Serum Biomarker Assay That Differentiates Tumor-Associated MUC5AC (NPC-1C ANTIGEN) from Normal MUC5AC

P. Arlen, A. Bristol, J. Luka, 2010, Journal of biomedicine & biotechnology.

Expression of epstein‐barr virus‐encoded proteins and B‐cell markers in fatal infectious mononucleosis

Jack R. Davis, I. Ernberg, G. Klein, 1990, International journal of cancer.

Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines

G. Klein, T. Lindahl, J. Luka, 1978, Journal of virology.

Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis

P. Tiberghien, J. Roudier, D. Wendling, 2000, Annals of the rheumatic diseases.

Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110.

J. Roudier, D. Carson, G. Rhodes, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Expression of Epstein‐Barr virus proteins in primary CNS lymphoma in AIDS patients

M. Chamberlain, F. Hochberg, R. Bashir, 1993, Neurology.

Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells

G. Klein, H. Jörnvall, B. Kallin, 1985, Journal of virology.

Persistent human herpesvirus‐6 infection in patients with an inherited form of the virus

Jesse H. Arbuckle, J. Montoya, Jianhong Hu, 2013, Journal of medical virology.

Chapter 10 Interactions between HHV-6 and other viruses

P. Lusso, D. Ablashi, J. Luka, 1992 .

Human herpesvirus‐6 (HHV‐6)‐associated necrotizing encephalitis in griscelli's syndrome

G. Krueger, J. Müller-Berghaus, N. Leyssens, 1997, Journal of medical virology.

Chapter 5 Infection, latency and immortalization of human cells with HHV-6

J. Luka, 1992 .

HHV-6 genome in T-cell acute lymphoblastic leukaemia

J. Kersey, S. Pirruccello, J. Luka, 1991, The Lancet.

Human Herpesvirus-6 (Human B-Lymphotrophic Virus)

S. Salahuddin, R. Gallo, S. Josephs, 1989 .

Interaction of HBLV (HHV-6) With EBV and HIV

R. Gallo, S. Josephs, P. Lusso, 1989 .

Immunochemical Characterization of Epstein-Barr Virus-Associated Early and Late Antigens in n-Butyrate-Treated P3HR-1 Cells

G. Klein, B. Kallin, J. Luka, 1979, Journal of virology.

Detection and characterization of EBV antigens by micro-ELISA and chromatofocusing.

G. Klein, B. Kallin, B. Vestergaard, 1982, Journal of virological methods.

Antibodies of predetermined specificity for the NH2 terminus of a cellular protein p53 react with the native molecule: evidence for the presence of different p53s.

G. Klein, H. Jörnvall, L. Sternås, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Isolation of human herpesvirus‐6 from clinical specimens using human fibroblast cultures

M. Okano, J. Luka, Geoffrey E. Thiele, 1990, Journal of clinical laboratory analysis.

Early DNA-binding polypeptides of Epstein-Barr virus.

G. Klein, B. Kallin, J. Roubal, 1981, Virology.

Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate.

G. Klein, J. Roubal, J. Luka, 1980, Cancer letters.

Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen.

G. Rhodes, R. Fox, J. Vaughan, 1986, The Journal of clinical investigation.

Human herpesvirus 6 infection and Kawasaki disease

Y. Sakiyama, G. Thiele, D. Purtilo, 1989, Journal of clinical microbiology.

Migration inhibition caused by ebv‐specific 48k subcomponent of ebna and the associated 53k cellular protein

G. Klein, G. Klein, L. Sternås, 1982, International journal of cancer.

Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin.

I. M. Shapiro, G. Klein, J. Luka, 1979, Intervirology.

Development of an enzyme‐linked immunosorbent assay (ELISA) for detecting IgA antibodies to the epstein‐barr virus

W. Uen, G. Pearson, J. Luka, 1988, International journal of cancer.

Characterization of a major protein with a molecular weight of 160,000 associated with the viral capsid of Epstein-Barr virus

M. Rodriguez, B. Vroman, G. Pearson, 1985, Journal of virology.

Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen.

J. Poduslo, M. Kishishita, B. Vroman, 1984, Virology.

A sensitive enzyme-linked immunosorbent assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigens.

R. Chase, G. Pearson, J. Luka, 1984, Journal of immunological methods.

Solubilization of the Epstein-Barr virus-determined nuclear antigen and its characterization as a DNA-binding protein

W. Siegert, G. Klein, J. Luka, 1977, Journal of virology.

The effect of leukocyte-reduction method on the amount of human cytomegalovirus in blood products: a comparison of apheresis and filtration methods.

D. Ambruso, L. Dumont, P. Whitley, 2001, Blood.

Detection of antigens associated with Epstein-Barr virus replication in extracts from biopsy specimens of nasopharyngeal carcinomas.

D. Hartmann, Z. Deeb, G. Pearson, 1988, Journal of the National Cancer Institute.

Establishment and characterization of a chronic infectious mononucleosislike syndrome in common marmosets

E. Emini, M. Armstrong, P. Provost, 1986, Journal of medical virology.

Dynamic time warping assessment of high-resolution melt curves provides a robust metric for fungal identification

Dongmei Li, Sayali S. Phatak, Sha Lu, 2017, PloS one.

Leukocyte migration inhibition studies with Epstein-Barr virus (EBV) determined nuclear antigen (EBNA) in relation to the EBV-carrier status of the donor.

G. Klein, J. Luka, R. Szigeti, 1981, Cellular immunology.

Membranes of EBV-carrying virus nonproducer cells inhibit leukocyte migration of EBV-seropositive but not seronegative donors.

G. Klein, D. Volsky, J. Luka, 1981, Journal of immunology.

The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro

Jesse H. Arbuckle, A. Komaroff, J. Montoya, 2010, Proceedings of the National Academy of Sciences.

Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.

G. Klein, B. Kallin, J. Luka, 1979, Virology.

Transformation induced by Epstein-Barr virus and the role of the nuclear antigen.

J. Zeuthen, G. Klein, J. Luka, 1980, Cold Spring Harbor symposia on quantitative biology.

Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.

E. Kieff, J. Sample, L. Petti, 1987, Virology.

HLA-DR polymorphism influences T-cell precursor frequencies to Epstein-Barr virus (EBV) gp110: implications for the association of HLA-DR antigens with rheumatoid arthritis.

P. Tiberghien, I. Auger, J. Roudier, 1999, Tissue antigens.

Identification of an Epstein-Barr virus glycoprotein which is antigenically homologous to the varicella-zoster virus glycoprotein II and the herpes simplex virus glycoprotein B.

E. Emini, P. Keller, M. Armstrong, 1987, Virology.

HHV-6A infection induces expression of HERV-K18-encoded superantigen.

B. Huber, A. Tai, D. Ablashi, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Characterization of the restricted component of Epstein-Barr virus early antigens as a cytoplasmic filamentous protein

H. Jörnvall, G. Miller, G. Pearson, 1986, Journal of virology.

Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSG and two pentapepfide seauence identities between EBNA A and myelin basic protein

P. Bray, P. Bray, J. Luka, 1992, Neurology.

Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes.

G. Klein, T. Lindahl, S. Ohno, 1977, Proceedings of the National Academy of Sciences of the United States of America.

Validation of hierarchical cluster analysis for identification of bacterial species using 42 bacterial isolates

Janos Luka, Nicole J. Crane, Meron Ghebremedhin, 2015, Photonics West - Biomedical Optics.

Early effect of gene therapy on a direct muscle neurotization model.

J. Terzis, K. Papakonstantinou, J. Luka, 2005, Journal of reconstructive microsurgery.

Activation of Epstein-Barr virus in latently infected cell lines.

J. Luka, 1988, Journal of virological methods.

Characterization of a human herpes virus-6 (HHV-6) and epstein-barr virus (EBV) associated leukemic cell line, J6-1

S. Joshi, S. Pirruccello, J. Graham Sharp, 1994 .

Interaction between Epstein-Barr virus-determined nuclear antigen (EBNA) and the viral DNA.

G. Klein, L. Gergely, J. Luka, 1984, The Journal of general virology.

Detection of a nuclear, EBNA‐type antigen in apparently EBNA‐negative Herpesvirus papio (HVP)‐transformed lymphoid lines by the acid‐fixed nuclear binding technique

G. Klein, S. Ohno, L. Falk, 1977, International journal of cancer.

Development of a new stool biomarker ELISA for the early detection of colorectal cancer.

P. Arlen, J. Luka, J. Bristol, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Human herpesvirus-6 (HHV-6) in Hodgkin's disease: cellular expression of viral antigens as compared to oncogenes met and fes, tumor suppressor gene product p53, and interleukins 2 and 6.

H. Tesch, G. Krueger, D. Ablashi, 1994, In vivo.

Multicenter evaluation of PCR methods fordetecting CMV DNA in blood donors

C. Hillyer, M. Busch, J. Roback, 2001, Transfusion.

Serological reactivities of human and baboon sera against EBNA and Herpesvirus papio-determined nuclear antigen (HUPNA).

G. Klein, S. Ohno, L. Falk, 1978, European journal of cancer.

A restricted component of the Epstein-Barr virus early antigen complex is structurally related to ribonucleotide reductase.

G. Pearson, W. Goldschmidts, J. Luka, 1987, Virology.

Inhibition of the EBV Lytic Cycle by Sequence Specific Antisense Oligonucleotides

I. Magrath, K. Bhatia, W. Goldschmidts, 1991 .

Detection of the EBV-determined nuclear antigen (EBNA) in Burkitt's lymphoma and nasopharyngeal carcinoma biopsies by the acid fixed nuclear binding (AFNB) technique.

G. Klein, W. Henle, G. Henle, 1978, Cancer letters.

The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro

Jesse H. Arbuckle, A. Komaroff, J. Montoya, 2010, Proceedings of the National Academy of Sciences.

Identification and characterization of a cellular protein that cross-reacts with the Epstein-Barr virus nuclear antigen

E. Kieff, K. Hennessy, G. Pearson, 1984, Journal of virology.

Characterization of Two Forms of the 72,000 MW EBNA and a Cross-Reacting Cellular Protein

E. Kieff, T. Spelsberg, K. Hennessey, 1985 .

A 53-kilodalton protein common to chemically and virally transformed cells shows extensive sequence similarities between species.

E. Appella, G. Klein, H. Jörnvall, 1982, Proceedings of the National Academy of Sciences of the United States of America.